img

Tumor Blood Testing


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF&Excel

Tumor Blood Testing

The global Tumor Blood Testing market is expected to reach US$ XX Million by 2033, with a CAGR of XX% from 2023 to 2033, based on MRA newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

Guardant Health

Roche

Trovagene

Genomic Health

Pathway Genomics

Bio-Techne



By Types

Blood Protein Testing

Tumor Marker Testing

Others



By Applications

Hospitals

Clinics

Ambulatory Surgical Centers



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2033 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2017-2033. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2023-2033)

1.4.2 East Asia Market States and Outlook (2023-2033)

1.4.3 Europe Market States and Outlook (2023-2033)

1.4.4 South Asia Market States and Outlook (2023-2033)

1.4.5 Southeast Asia Market States and Outlook (2023-2033)

1.4.6 Middle East Market States and Outlook (2023-2033)

1.4.7 Africa Market States and Outlook (2023-2033)

1.4.8 Oceania Market States and Outlook (2023-2033)

1.4.9 South America Market States and Outlook (2023-2033)

1.5 Global Tumor Blood Testing Market Size Analysis from 2023 to 2033

1.5.1 Global Tumor Blood Testing Market Size Analysis from 2023 to 2033 by Consumption Volume

1.5.2 Global Tumor Blood Testing Market Size Analysis from 2023 to 2033 by Value

1.5.3 Global Tumor Blood Testing Price Trends Analysis from 2023 to 2033

1.6 COVID-19 Outbreak: Tumor Blood Testing Industry Impact

Chapter 2 Global Tumor Blood Testing Competition by Types, Applications, and Top Regions and Countries

2.1 Global Tumor Blood Testing (Volume and Value) by Type

2.1.1 Global Tumor Blood Testing Consumption and Market Share by Type (2017-2022)

2.1.2 Global Tumor Blood Testing Revenue and Market Share by Type (2017-2022)

2.2 Global Tumor Blood Testing (Volume and Value) by Application

2.2.1 Global Tumor Blood Testing Consumption and Market Share by Application (2017-2022)

2.2.2 Global Tumor Blood Testing Revenue and Market Share by Application (2017-2022)

2.3 Global Tumor Blood Testing (Volume and Value) by Regions

2.3.1 Global Tumor Blood Testing Consumption and Market Share by Regions (2017-2022)

2.3.2 Global Tumor Blood Testing Revenue and Market Share by Regions (2017-2022)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2017-2022 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2017-2022 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Tumor Blood Testing Sales, Consumption, Export, Import by Regions (2017-2022)

4.1 Global Tumor Blood Testing Consumption by Regions (2017-2022)

4.2 North America Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.3 East Asia Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.4 Europe Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.5 South Asia Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.6 Southeast Asia Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.7 Middle East Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.8 Africa Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.9 Oceania Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

4.10 South America Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Chapter 5 North America Tumor Blood Testing Market Analysis

5.1 North America Tumor Blood Testing Consumption and Value Analysis

5.1.1 North America Tumor Blood Testing Market Under COVID-19

5.2 North America Tumor Blood Testing Consumption Volume by Types

5.3 North America Tumor Blood Testing Consumption Structure by Application

5.4 North America Tumor Blood Testing Consumption by Top Countries

5.4.1 United States Tumor Blood Testing Consumption Volume from 2017 to 2022

5.4.2 Canada Tumor Blood Testing Consumption Volume from 2017 to 2022

5.4.3 Mexico Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 6 East Asia Tumor Blood Testing Market Analysis

6.1 East Asia Tumor Blood Testing Consumption and Value Analysis

6.1.1 East Asia Tumor Blood Testing Market Under COVID-19

6.2 East Asia Tumor Blood Testing Consumption Volume by Types

6.3 East Asia Tumor Blood Testing Consumption Structure by Application

6.4 East Asia Tumor Blood Testing Consumption by Top Countries

6.4.1 China Tumor Blood Testing Consumption Volume from 2017 to 2022

6.4.2 Japan Tumor Blood Testing Consumption Volume from 2017 to 2022

6.4.3 South Korea Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 7 Europe Tumor Blood Testing Market Analysis

7.1 Europe Tumor Blood Testing Consumption and Value Analysis

7.1.1 Europe Tumor Blood Testing Market Under COVID-19

7.2 Europe Tumor Blood Testing Consumption Volume by Types

7.3 Europe Tumor Blood Testing Consumption Structure by Application

7.4 Europe Tumor Blood Testing Consumption by Top Countries

7.4.1 Germany Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.2 UK Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.3 France Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.4 Italy Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.5 Russia Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.6 Spain Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.7 Netherlands Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.8 Switzerland Tumor Blood Testing Consumption Volume from 2017 to 2022

7.4.9 Poland Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 8 South Asia Tumor Blood Testing Market Analysis

8.1 South Asia Tumor Blood Testing Consumption and Value Analysis

8.1.1 South Asia Tumor Blood Testing Market Under COVID-19

8.2 South Asia Tumor Blood Testing Consumption Volume by Types

8.3 South Asia Tumor Blood Testing Consumption Structure by Application

8.4 South Asia Tumor Blood Testing Consumption by Top Countries

8.4.1 India Tumor Blood Testing Consumption Volume from 2017 to 2022

8.4.2 Pakistan Tumor Blood Testing Consumption Volume from 2017 to 2022

8.4.3 Bangladesh Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 9 Southeast Asia Tumor Blood Testing Market Analysis

9.1 Southeast Asia Tumor Blood Testing Consumption and Value Analysis

9.1.1 Southeast Asia Tumor Blood Testing Market Under COVID-19

9.2 Southeast Asia Tumor Blood Testing Consumption Volume by Types

9.3 Southeast Asia Tumor Blood Testing Consumption Structure by Application

9.4 Southeast Asia Tumor Blood Testing Consumption by Top Countries

9.4.1 Indonesia Tumor Blood Testing Consumption Volume from 2017 to 2022

9.4.2 Thailand Tumor Blood Testing Consumption Volume from 2017 to 2022

9.4.3 Singapore Tumor Blood Testing Consumption Volume from 2017 to 2022

9.4.4 Malaysia Tumor Blood Testing Consumption Volume from 2017 to 2022

9.4.5 Philippines Tumor Blood Testing Consumption Volume from 2017 to 2022

9.4.6 Vietnam Tumor Blood Testing Consumption Volume from 2017 to 2022

9.4.7 Myanmar Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 10 Middle East Tumor Blood Testing Market Analysis

10.1 Middle East Tumor Blood Testing Consumption and Value Analysis

10.1.1 Middle East Tumor Blood Testing Market Under COVID-19

10.2 Middle East Tumor Blood Testing Consumption Volume by Types

10.3 Middle East Tumor Blood Testing Consumption Structure by Application

10.4 Middle East Tumor Blood Testing Consumption by Top Countries

10.4.1 Turkey Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.2 Saudi Arabia Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.3 Iran Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.4 United Arab Emirates Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.5 Israel Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.6 Iraq Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.7 Qatar Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.8 Kuwait Tumor Blood Testing Consumption Volume from 2017 to 2022

10.4.9 Oman Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 11 Africa Tumor Blood Testing Market Analysis

11.1 Africa Tumor Blood Testing Consumption and Value Analysis

11.1.1 Africa Tumor Blood Testing Market Under COVID-19

11.2 Africa Tumor Blood Testing Consumption Volume by Types

11.3 Africa Tumor Blood Testing Consumption Structure by Application

11.4 Africa Tumor Blood Testing Consumption by Top Countries

11.4.1 Nigeria Tumor Blood Testing Consumption Volume from 2017 to 2022

11.4.2 South Africa Tumor Blood Testing Consumption Volume from 2017 to 2022

11.4.3 Egypt Tumor Blood Testing Consumption Volume from 2017 to 2022

11.4.4 Algeria Tumor Blood Testing Consumption Volume from 2017 to 2022

11.4.5 Morocco Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 12 Oceania Tumor Blood Testing Market Analysis

12.1 Oceania Tumor Blood Testing Consumption and Value Analysis

12.2 Oceania Tumor Blood Testing Consumption Volume by Types

12.3 Oceania Tumor Blood Testing Consumption Structure by Application

12.4 Oceania Tumor Blood Testing Consumption by Top Countries

12.4.1 Australia Tumor Blood Testing Consumption Volume from 2017 to 2022

12.4.2 New Zealand Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 13 South America Tumor Blood Testing Market Analysis

13.1 South America Tumor Blood Testing Consumption and Value Analysis

13.1.1 South America Tumor Blood Testing Market Under COVID-19

13.2 South America Tumor Blood Testing Consumption Volume by Types

13.3 South America Tumor Blood Testing Consumption Structure by Application

13.4 South America Tumor Blood Testing Consumption Volume by Major Countries

13.4.1 Brazil Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.2 Argentina Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.3 Columbia Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.4 Chile Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.5 Venezuela Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.6 Peru Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.7 Puerto Rico Tumor Blood Testing Consumption Volume from 2017 to 2022

13.4.8 Ecuador Tumor Blood Testing Consumption Volume from 2017 to 2022

Chapter 14 Company Profiles and Key Figures in Tumor Blood Testing Business

14.1 Guardant Health

14.1.1 Guardant Health Company Profile

14.1.2 Guardant Health Tumor Blood Testing Product Specification

14.1.3 Guardant Health Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.2 Roche

14.2.1 Roche Company Profile

14.2.2 Roche Tumor Blood Testing Product Specification

14.2.3 Roche Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.3 Trovagene

14.3.1 Trovagene Company Profile

14.3.2 Trovagene Tumor Blood Testing Product Specification

14.3.3 Trovagene Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.4 Genomic Health

14.4.1 Genomic Health Company Profile

14.4.2 Genomic Health Tumor Blood Testing Product Specification

14.4.3 Genomic Health Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.5 Pathway Genomics

14.5.1 Pathway Genomics Company Profile

14.5.2 Pathway Genomics Tumor Blood Testing Product Specification

14.5.3 Pathway Genomics Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

14.6 Bio-Techne

14.6.1 Bio-Techne Company Profile

14.6.2 Bio-Techne Tumor Blood Testing Product Specification

14.6.3 Bio-Techne Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Chapter 15 Global Tumor Blood Testing Market Forecast (2023-2033)

15.1 Global Tumor Blood Testing Consumption Volume, Revenue and Price Forecast (2023-2033)

15.1.1 Global Tumor Blood Testing Consumption Volume and Growth Rate Forecast (2023-2033)

15.1.2 Global Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

15.2 Global Tumor Blood Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2033)

15.2.1 Global Tumor Blood Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2033)

15.2.2 Global Tumor Blood Testing Value and Growth Rate Forecast by Regions (2023-2033)

15.2.3 North America Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.4 East Asia Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.5 Europe Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.6 South Asia Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.7 Southeast Asia Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.8 Middle East Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.9 Africa Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.10 Oceania Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.2.11 South America Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2033)

15.3 Global Tumor Blood Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2033)

15.3.1 Global Tumor Blood Testing Consumption Forecast by Type (2023-2033)

15.3.2 Global Tumor Blood Testing Revenue Forecast by Type (2023-2033)

15.3.3 Global Tumor Blood Testing Price Forecast by Type (2023-2033)

15.4 Global Tumor Blood Testing Consumption Volume Forecast by Application (2023-2033)

15.5 Tumor Blood Testing Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology



List of Figure

Figure Product Picture

Figure North America Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure United States Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Canada Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Mexico Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure East Asia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure China Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Japan Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure South Korea Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Europe Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Germany Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure UK Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure France Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Italy Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Russia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Spain Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Netherlands Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Switzerland Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Poland Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure South Asia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure India Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Pakistan Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Bangladesh Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Southeast Asia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Indonesia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Thailand Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Singapore Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Malaysia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Philippines Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Vietnam Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Myanmar Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Middle East Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Turkey Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Saudi Arabia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Iran Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure United Arab Emirates Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Israel Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Iraq Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Qatar Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Kuwait Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Oman Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Africa Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Nigeria Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure South Africa Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Egypt Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Algeria Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Algeria Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Oceania Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Australia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure New Zealand Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure South America Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Brazil Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Argentina Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Columbia Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Chile Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Venezuela Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Peru Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Puerto Rico Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Ecuador Tumor Blood Testing Revenue ($) and Growth Rate (2023-2033)

Figure Global Tumor Blood Testing Market Size Analysis from 2023 to 2033 by Consumption Volume

Figure Global Tumor Blood Testing Market Size Analysis from 2023 to 2033 by Value

Table Global Tumor Blood Testing Price Trends Analysis from 2023 to 2033

Table Global Tumor Blood Testing Consumption and Market Share by Type (2017-2022)

Table Global Tumor Blood Testing Revenue and Market Share by Type (2017-2022)

Table Global Tumor Blood Testing Consumption and Market Share by Application (2017-2022)

Table Global Tumor Blood Testing Revenue and Market Share by Application (2017-2022)

Table Global Tumor Blood Testing Consumption and Market Share by Regions (2017-2022)

Table Global Tumor Blood Testing Revenue and Market Share by Regions (2017-2022)

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Major Manufacturers Capacity and Total Capacity

Table 2017-2022 Major Manufacturers Capacity Market Share

Table 2017-2022 Major Manufacturers Production and Total Production

Table 2017-2022 Major Manufacturers Production Market Share

Table 2017-2022 Major Manufacturers Revenue and Total Revenue

Table 2017-2022 Major Manufacturers Revenue Market Share

Table 2017-2022 Regional Market Capacity and Market Share

Table 2017-2022 Regional Market Production and Market Share

Table 2017-2022 Regional Market Revenue and Market Share

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin

Figure 2017-2022 Capacity, Production and Growth Rate

Figure 2017-2022 Revenue, Gross Margin and Growth Rate

Table Global Tumor Blood Testing Consumption by Regions (2017-2022)

Figure Global Tumor Blood Testing Consumption Share by Regions (2017-2022)

Table North America Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table East Asia Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table Europe Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table South Asia Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table Southeast Asia Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table Middle East Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table Africa Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table Oceania Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Table South America Tumor Blood Testing Sales, Consumption, Export, Import (2017-2022)

Figure North America Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure North America Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table North America Tumor Blood Testing Sales Price Analysis (2017-2022)

Table North America Tumor Blood Testing Consumption Volume by Types

Table North America Tumor Blood Testing Consumption Structure by Application

Table North America Tumor Blood Testing Consumption by Top Countries

Figure United States Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Canada Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Mexico Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure East Asia Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure East Asia Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table East Asia Tumor Blood Testing Sales Price Analysis (2017-2022)

Table East Asia Tumor Blood Testing Consumption Volume by Types

Table East Asia Tumor Blood Testing Consumption Structure by Application

Table East Asia Tumor Blood Testing Consumption by Top Countries

Figure China Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Japan Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure South Korea Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Europe Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure Europe Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table Europe Tumor Blood Testing Sales Price Analysis (2017-2022)

Table Europe Tumor Blood Testing Consumption Volume by Types

Table Europe Tumor Blood Testing Consumption Structure by Application

Table Europe Tumor Blood Testing Consumption by Top Countries

Figure Germany Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure UK Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure France Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Italy Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Russia Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Spain Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Netherlands Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Switzerland Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Poland Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure South Asia Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure South Asia Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table South Asia Tumor Blood Testing Sales Price Analysis (2017-2022)

Table South Asia Tumor Blood Testing Consumption Volume by Types

Table South Asia Tumor Blood Testing Consumption Structure by Application

Table South Asia Tumor Blood Testing Consumption by Top Countries

Figure India Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Pakistan Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Bangladesh Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Southeast Asia Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure Southeast Asia Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table Southeast Asia Tumor Blood Testing Sales Price Analysis (2017-2022)

Table Southeast Asia Tumor Blood Testing Consumption Volume by Types

Table Southeast Asia Tumor Blood Testing Consumption Structure by Application

Table Southeast Asia Tumor Blood Testing Consumption by Top Countries

Figure Indonesia Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Thailand Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Singapore Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Malaysia Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Philippines Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Vietnam Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Myanmar Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Middle East Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure Middle East Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table Middle East Tumor Blood Testing Sales Price Analysis (2017-2022)

Table Middle East Tumor Blood Testing Consumption Volume by Types

Table Middle East Tumor Blood Testing Consumption Structure by Application

Table Middle East Tumor Blood Testing Consumption by Top Countries

Figure Turkey Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Saudi Arabia Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Iran Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure United Arab Emirates Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Israel Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Iraq Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Qatar Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Kuwait Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Oman Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Africa Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure Africa Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table Africa Tumor Blood Testing Sales Price Analysis (2017-2022)

Table Africa Tumor Blood Testing Consumption Volume by Types

Table Africa Tumor Blood Testing Consumption Structure by Application

Table Africa Tumor Blood Testing Consumption by Top Countries

Figure Nigeria Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure South Africa Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Egypt Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Algeria Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Algeria Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Oceania Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure Oceania Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table Oceania Tumor Blood Testing Sales Price Analysis (2017-2022)

Table Oceania Tumor Blood Testing Consumption Volume by Types

Table Oceania Tumor Blood Testing Consumption Structure by Application

Table Oceania Tumor Blood Testing Consumption by Top Countries

Figure Australia Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure New Zealand Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure South America Tumor Blood Testing Consumption and Growth Rate (2017-2022)

Figure South America Tumor Blood Testing Revenue and Growth Rate (2017-2022)

Table South America Tumor Blood Testing Sales Price Analysis (2017-2022)

Table South America Tumor Blood Testing Consumption Volume by Types

Table South America Tumor Blood Testing Consumption Structure by Application

Table South America Tumor Blood Testing Consumption Volume by Major Countries

Figure Brazil Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Argentina Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Columbia Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Chile Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Venezuela Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Peru Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Puerto Rico Tumor Blood Testing Consumption Volume from 2017 to 2022

Figure Ecuador Tumor Blood Testing Consumption Volume from 2017 to 2022

Guardant Health Tumor Blood Testing Product Specification

Guardant Health Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Roche Tumor Blood Testing Product Specification

Roche Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Trovagene Tumor Blood Testing Product Specification

Trovagene Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Genomic Health Tumor Blood Testing Product Specification

Table Genomic Health Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Pathway Genomics Tumor Blood Testing Product Specification

Pathway Genomics Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Bio-Techne Tumor Blood Testing Product Specification

Bio-Techne Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)

Figure Global Tumor Blood Testing Consumption Volume and Growth Rate Forecast (2023-2033)

Figure Global Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Table Global Tumor Blood Testing Consumption Volume Forecast by Regions (2023-2033)

Table Global Tumor Blood Testing Value Forecast by Regions (2023-2033)

Figure North America Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure North America Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure United States Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure United States Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Canada Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Canada Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Mexico Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Mexico Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure East Asia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure East Asia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure China Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure China Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Japan Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Japan Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure South Korea Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure South Korea Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Europe Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Europe Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Germany Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Germany Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure UK Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure UK Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure France Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure France Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Italy Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Italy Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Russia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Russia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Spain Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Spain Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Netherlands Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Netherlands Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Swizerland Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Swizerland Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Poland Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Poland Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure South Asia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure South Asia a Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure India Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure India Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Pakistan Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Pakistan Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Bangladesh Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Bangladesh Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Southeast Asia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Southeast Asia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Indonesia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Indonesia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Thailand Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Thailand Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Singapore Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Singapore Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Malaysia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Malaysia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Philippines Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Philippines Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Vietnam Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Vietnam Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Myanmar Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Myanmar Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Middle East Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Middle East Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Turkey Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Turkey Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Saudi Arabia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Saudi Arabia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Iran Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Iran Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure United Arab Emirates Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure United Arab Emirates Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Israel Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Israel Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Iraq Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Iraq Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Qatar Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Qatar Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Kuwait Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Kuwait Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Oman Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Oman Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Africa Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Africa Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Nigeria Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Nigeria Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure South Africa Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure South Africa Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Egypt Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Egypt Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Algeria Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Algeria Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Morocco Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Morocco Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Oceania Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Oceania Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Australia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Australia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure New Zealand Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure New Zealand Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure South America Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure South America Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Brazil Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Brazil Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Argentina Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Argentina Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Columbia Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Columbia Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Chile Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Chile Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Venezuela Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Venezuela Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Peru Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Peru Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Puerto Rico Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Puerto Rico Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Figure Ecuador Tumor Blood Testing Consumption and Growth Rate Forecast (2023-2033)

Figure Ecuador Tumor Blood Testing Value and Growth Rate Forecast (2023-2033)

Table Global Tumor Blood Testing Consumption Forecast by Type (2023-2033)

Table Global Tumor Blood Testing Revenue Forecast by Type (2023-2033)

Figure Global Tumor Blood Testing Price Forecast by Type (2023-2033)

Table Global Tumor Blood Testing Consumption Volume Forecast by Application (2023-2033)